Pharmacokinetic of Levodopa Study in Healthy Males
Status:
Completed
Trial end date:
2017-08-03
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate PK of levodopa in plasma after repeated doses of 3
levodopa formulations given in combination with carbidopa and ODM-104 and compared to the PK
of standard IR and CR levodopa formulations in the same combination.
Phase:
Phase 1
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa